Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Phern Chern Tor, Nurmiati Amir, Johnson Fam, Roger Ho, Pichai Ittasakul, Margarita M Maramis, Benita Ponio, Dharmawan Ardi Purnama, Wanida Rattanasumawong, Elizabeth Rondain, Ahmad Hatim Bin Sulaiman, Kannokarn Wiroteurairuang & Kok Yoon Chee. (2022) A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression. Neuropsychiatric Disease and Treatment 18, pages 2747-2757.
Read now
Read now
Seetal Dodd, Michael Bauer, Andre F. Carvalho, Harris Eyre, Maurizio Fava, Siegfried Kasper, Sidney H. Kennedy, Jon-Paul Khoo, Carlos Lopez Jaramillo, Gin S. Malhi, Roger S. McIntyre, Philip B. Mitchell, Angela Marianne Paredes Castro, Aswin Ratheesh, Emanuel Severus, Trisha Suppes, Madhukar H. Trivedi, Michael E. Thase, Lakshmi N. Yatham, Allan H. Young & Michael Berk. (2021) A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?. The World Journal of Biological Psychiatry 22:7, pages 483-494.
Read now
Read now
Siegfried Kasper, Wiesław J. Cubała, Andrea Fagiolini, Josep A. Ramos-Quiroga, Daniel Souery & Allan H. Young. (2021) Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance. The World Journal of Biological Psychiatry 22:6, pages 468-482.
Read now
Read now
Maryia Zhdanava, Harsh Kuvadia, Kruti Joshi, Ella Daly, Dominic Pilon, Carmine Rossi, Laura Morrison, Patrick Lefebvre & Craig Nelson. (2021) Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder. Current Medical Research and Opinion 37:1, pages 123-133.
Read now
Read now
Khalid Saad Al-Harbi. (2012) Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Preference and Adherence 6, pages 369-388.
Read now
Read now
Articles from other publishers (42)
Lalit Kaurani, Matthias Besse, Isabel Methfessel, Aditi Methi, Jiayin Zhou, Ranjit Pradhan, Susanne Burkhardt, Laura Kranaster, Alexander Sartorius, Ute Habel, Michael Grözinger, Andre Fischer, Jens Wiltfang & David Zilles-Wegner. (2023) Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression. Translational Psychiatry 13:1.
Crossref
Crossref
Tamadhir Al-Mahrouqi, Mohammed Al Alawi & Rafael C. Freire. (2023) Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review. Clinical Practice & Epidemiology in Mental Health 19:1.
Crossref
Crossref
Gin S. Malhi, Erica Bell, Darryl Bassett, Philip Boyce, Malcolm Hopwood, Roger Mulder & Richard Porter. (2023) Difficult decision‐making in major depressive disorder: Practical guidance based on clinical research and experience. Bipolar Disorders 25:5, pages 355-378.
Crossref
Crossref
Marco Aurélio Cigognini, Alia Garrudo Guirado, Denise van de Meene, Mônica Andréia Schneider, Mônica Sarah Salomon, Vinicius Santana de Alexandria, Juliana Pisseta Adriano, Ana Maria Thaler, Fernando dos Santos Fernandes, Adriana Carneiro & Ricardo Alberto Moreno. (2022) Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial. Frontiers in Psychiatry 13.
Crossref
Crossref
Rai Khalid Farooq, Widyan Alamoudi, Amani Alhibshi, Suriya Rehman, Ashish Ranjan Sharma & Fuad A. Abdulla. (2022) Varied Composition and Underlying Mechanisms of Gut Microbiome in Neuroinflammation. Microorganisms 10:4, pages 705.
Crossref
Crossref
Pham Thi Thu Huong, Chia-Yi Wu, Ming-Been Lee & I-Ming Chen. (2022) Associations of Suicide Risk and Community Integration Among Patients With Treatment-Resistant Depression. Frontiers in Psychiatry 13.
Crossref
Crossref
Adam Włodarczyk, Wiesław J. Cubała & Mateusz Stawicki. (2021) Ketogenic diet for depression: A potential dietary regimen to maintain euthymia?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 109, pages 110257.
Crossref
Crossref
S. A. Galkin, S. N. Vasilieva, S. A. Ivanova & N. A. Bokhan. (2021) Electroencephalographic Markers of Depressive Disorders Resistance to Pharmacotherapy and Determination of a Possible Approach to Individual Prognosis of Therapy Effectiveness. Psikhiatriya 19:2, pages 39-45.
Crossref
Crossref
Melinda E. Snitow, Rahul S. Bhansali & Peter S. Klein. (2021) Lithium and Therapeutic Targeting of GSK-3. Cells 10:2, pages 255.
Crossref
Crossref
Tobias Gerhard, T. Scott Stroup, Christoph U. Correll, Soko Setoguchi, Brian L. Strom, Cecilia Huang, Zhiqiang Tan, Stephen Crystal & Mark Olfson. (2021) Mortality Risk of Antipsychotic Augmentation for Adult Depression. FOCUS 19:1, pages 86-94.
Crossref
Crossref
Tobias Gerhard, T. Scott Stroup, Christoph U. Correll, Soko Setoguchi, Brian L. Strom, Cecilia Huang, Zhiqiang Tan, Stephen Crystal & Mark Olfson. (2020) Mortality risk of antipsychotic augmentation for adult depression. PLOS ONE 15:9, pages e0239206.
Crossref
Crossref
Jose Alfonso Ontiveros. 2019. Antidepressants - Preclinical, Clinical and Translational Aspects. Antidepressants - Preclinical, Clinical and Translational Aspects.
Namwoo Kim, Sung Joon Cho, Hyeyoung Kim, Se Hyun Kim, Hyun Jeong Lee, C. Hyung Keun Park, Sang Jin Rhee, Daewook Kim, Bo Ram Yang, So-Hyun Choi, GumJee Choi, MinJung Koh & Yong Min Ahn. (2019) Epidemiology of pharmaceutically treated depression and treatment resistant depression in South Korea. PLOS ONE 14:8, pages e0221552.
Crossref
Crossref
Atsushi Suzuki, Koji Murakami, Yasukazu Tajima, Hiroe Hara, Akiyoshi Kunugi & Haruhide Kimura. (2019) TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats. Pharmacology Biochemistry and Behavior 183, pages 80-86.
Crossref
Crossref
Harold A. Sackeim, Scott T. Aaronson, Mark T. Bunker, Charles R. Conway, Mark A. Demitrack, Mark S. George, Joan Prudic, Michael E. Thase & A. John Rush. (2019) The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). Journal of Psychiatric Research 113, pages 125-136.
Crossref
Crossref
Nathalie Alvarez-Ricartes, Patricia Oliveros-Matus, Cristhian Mendoza, Nelson Perez-Urrutia, Florencia Echeverria, Alexandre Iarkov, George E. Barreto & Valentina Echeverria. (2018) Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice. Molecular Neurobiology 55:10, pages 7949-7960.
Crossref
Crossref
Gianluca Serafini, Jacopo Nebbia, Nicolò Cipriani, Claudia Conigliaro, Denise Erbuto, Maurizio Pompili & Mario Amore. (2018) Number of illness episodes as predictor of residual symptoms in major depressive disorder. Psychiatry Research 262, pages 469-476.
Crossref
Crossref
Kathleen J. Maheras, Marcello Peppi, Farhad Ghoddoussi, Matthew P. Galloway, Shane A. Perrine & Alexander Gow. (2018) Absence of Claudin 11 in CNS Myelin Perturbs Behavior and Neurotransmitter Levels in Mice. Scientific Reports 8:1.
Crossref
Crossref
Khedidja Hedna, Karolina Andersson Sundell, Armina Hamidi, Ingmar Skoog, Sara Gustavsson & Margda Waern. (2017) Antidepressants and suicidal behaviour in late life: a prospective population-based study of use patterns in new users aged 75 and above. European Journal of Clinical Pharmacology 74:2, pages 201-208.
Crossref
Crossref
Jing-jing Zhou, Jian Yang, Xiao-hua Zhang & Gang Wang. (2018) Vagus nerve stimulation for treatment-resistant depression: protocol for a pilot self-controlled trial. Asia Pacific Journal of Clinical Trials: Nervous System Diseases 3:1, pages 22.
Crossref
Crossref
Sarel Jacobus Brand & Brian Herbert Harvey. (2016) Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies. Acta Neuropsychiatrica 29:4, pages 207-221.
Crossref
Crossref
Julia Kleeblatt, Felix Betzler, Laura L. Kilarski, Tom Bschor & Stephan Köhler. (2017) Efficacy of off-label augmentation in unipolar depression: A systematic review of the evidence. European Neuropsychopharmacology 27:5, pages 423-441.
Crossref
Crossref
Jaya Thomas, R. Khanam & Divya Vohora. (2016) Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway. Neurochemistry International 99, pages 103-109.
Crossref
Crossref
Scott R. Penzak. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
91
119
.
Kurt‐Wolfram Sühs, Christoph Correll, Christian K. Eberlein, Refik Pul, Helge Frieling, Stefan Bleich & Kai G. Kahl. (2015) Combination of agomelatine and bupropion for treatment‐resistant depression: results from a chart review study including a matched control group. Brain and Behavior 5:4.
Crossref
Crossref
Wissam El-Hage, Patrick Vourc’h, Philippe Gaillard, Julie Léger, Catherine Belzung, Yadira Ibarguen-Vargas, Christian R. Andres & Vincent Camus. (2014) The BDNF Val66Met polymorphism is associated with escitalopram response in depressed patients. Psychopharmacology 232:3, pages 575-581.
Crossref
Crossref
Irvin Epstein, Isaac Szpindel & Martin A. Katzman. (2014) Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies. Psychiatry Research 220, pages S15-S33.
Crossref
Crossref
Alexander Bystritsky, Jessica Danial & David Kronemyer. (2014) Interactions Between Diabetes and Anxiety and Depression. Endocrinology and Metabolism Clinics of North America 43:1, pages 269-283.
Crossref
Crossref
Nicole Kubitz, Maneesha Mehra, Ravi C. Potluri, Nitesh Garg & Nicole Cossrow. (2013) Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database. PLoS ONE 8:10, pages e76882.
Crossref
Crossref
Chia-Ming Chang, Soichiro Sato & Changsu Han. (2013) Evidence for the Benefits of Nonantipsychotic Pharmacological Augmentation in the Treatment of Depression. CNS Drugs 27:S1, pages 21-27.
Crossref
Crossref
Siegfried Kasper & Stuart MontgomerySiegfried Kasper & Elena Akimova. 2013. Treatment‐resistant Depression. Treatment‐resistant Depression
107
128
.
Yumiko Akamine, Norio Yasui-Furukori, Ichiro Ieiri & Tsukasa Uno. (2012) Psychotropic Drug–Drug Interactions Involving P-Glycoprotein. CNS Drugs 26:11, pages 959-973.
Crossref
Crossref
Baumeister Harald & Parker Gordon. (2012) Meta-review of depressive subtyping models. Journal of Affective Disorders 139:2, pages 126-140.
Crossref
Crossref
Thomas E Schlaepfer, Hans Ågren, Palmiero Monteleone, Cristobal Gasto, William Pitchot, Frederick Rouillon, David J Nutt & Siegfried Kasper. (2012) The hidden third: improving outcome in treatment-resistant depression. Journal of Psychopharmacology 26:5, pages 587-602.
Crossref
Crossref
Jordan R Covvey, Alexis Noble Crawford & Denise K Lowe. (2012) Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder. Annals of Pharmacotherapy 46:1, pages 117-123.
Crossref
Crossref
Fionn E O'Brien, Timothy G Dinan, Brendan T Griffin & John F Cryan. (2011)
Interactions between antidepressants and P‐glycoprotein at the blood–brain barrier: clinical significance of
in vitro
and
in vivo
findings
. British Journal of Pharmacology 165:2, pages 289-312.
Crossref
Crossref
Nicholas J. Brandon & Akira Sawa. (2011) Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nature Reviews Neuroscience 12:12, pages 707-722.
Crossref
Crossref
Cesario Bellantuono. (2011) La depressione maggiore resistente: update delle strategie di trattamento farmacologico. Quaderni Italiani di Psichiatria 30:3, pages 106-114.
Crossref
Crossref
Jason S. Wright & Jaak Panksepp. (2011) Toward affective circuit-based preclinical models of depression: Sensitizing dorsal PAG arousal leads to sustained suppression of positive affect in rats. Neuroscience & Biobehavioral Reviews 35:9, pages 1902-1915.
Crossref
Crossref
Bernardo Carpiniello. (2011) La risposta subottimale al trattamento antidepressivo: definizione e implicazioni cliniche. Quaderni Italiani di Psichiatria 30:2, pages 58-64.
Crossref
Crossref
Noah S. Philip, Linda L. Carpenter, Audrey R. Tyrka & Lawrence H. Price. (2010) Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology 212:1, pages 1-12.
Crossref
Crossref
Thomas E. Schlaepfer, S.H. Lisanby & Stefano Pallanti. (2014)
Separating Hope from Hype:
Some Ethical Implications of the Development of Deep Brain Stimulation in Psychiatric Research and Treatment
. CNS Spectrums 15:5, pages 285-287.
Crossref
Crossref